| abstract |
The present invention relates to compounds of formula (I), wherein Y, R1, and R3 are defined in the detailed description and claims, and pharmaceutically acceptable salts thereof. In addition, the present invention relates to processes for the preparation and use of the compounds of formula (I) and pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists of the TRPA1 channel and may be useful in the treatment of inflammatory diseases and disorders associated with this channel. |